SIGA Technologies/$SIGA

13:30
03:10
16:45
06:25
20:00
1D1W1MYTD1Y5YMAX

About SIGA Technologies

SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.

Ticker

$SIGA
Primary listing

Industry

Pharmaceuticals

Employees

46

ISIN

US8269171067

SIGA Metrics

BasicAdvanced
$459M
9.57
$0.67
0.93
$0.60
9.35%

What the Analysts think about SIGA

Analyst ratings (Buy, Hold, Sell) for SIGA Technologies stock.

Bulls say / Bears say

SIGA Technologies secured a $9 million contract with the U.S. Department of Defense for the procurement of TPOXX®, marking the third DOD contract in three years. (stocktitan.net)
The company reported strong financial results for 2024, achieving $133 million in product sales and $70 million in pre-tax operating income, indicating robust growth. (stocktitan.net)
TPOXX® received regulatory approval in Japan for treating smallpox, mpox, cowpox, and vaccination complications, expanding its international market presence. (stocktitan.net)
The PALM 007 clinical trial for TPOXX® in treating mpox failed to meet its primary endpoint, raising concerns about its efficacy for this indication. (marketwirenews.com)
SIGA's Chief Medical Officer, Dr. Jay Varma, was abruptly terminated without explanation, potentially indicating internal challenges. (marketwirenews.com)
A video surfaced allegedly showing Dr. Varma discussing concerns about TPOXX®'s data and the need to manage public perception, which could impact investor confidence. (marketwirenews.com)
Data summarised monthly by Lightyear AI. Last updated on 9 Jun 2025.

SIGA Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

SIGA Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $SIGA

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

No upcoming events
FAQs